2023
Time to reconsider the role of donor hepatitis C status in the Kidney Donor Risk Index
Potluri V, Kulkarni S. Time to reconsider the role of donor hepatitis C status in the Kidney Donor Risk Index. American Journal Of Transplantation 2023, 23: 595-596. PMID: 36775203, PMCID: PMC11181137, DOI: 10.1016/j.ajt.2023.02.013.Peer-Reviewed Original Research
2011
Successful Treatment of Fibrosing Cholestatic Hepatitis After Liver Transplantation
Cimsit B, Assis D, Caldwell C, Arvelakis A, Taddei T, Kulkarni S, Schilsky M, Emre S. Successful Treatment of Fibrosing Cholestatic Hepatitis After Liver Transplantation. Transplantation Proceedings 2011, 43: 905-908. PMID: 21486625, DOI: 10.1016/j.transproceed.2011.02.034.Peer-Reviewed Case Reports and Technical NotesConceptsLiver allograft rejectionHepatitis C virusRenal graft rejectionAllograft rejectionHCV recurrenceCholestatic hepatitisGraft rejectionHCV RNAPatient survivalEnd-stage liver disease (MELD) scoreOne-year patient survivalIFN/RBV therapyFIBROSING CHOLESTATIC HEPATITISHistologic HCV recurrenceIFN/ribavirinOne-year graftSuccessful salvage strategiesTime of OLTHCV RNA levelsLiver Disease scoreAnti-HCV therapyCohort of patientsEarly graft failureFCH groupOLT recipients
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply